FDA inspector Chen Wen-hsiung and 17 others, including pharmaceutical company owners, were questioned by the New Taipei City District Prosecutors’ Office as part of a year-long Anti-Corruption Act probe.
The inspector allegedly made more than $150,000 in the past two years by providing the time and date of “unannounced” FDA inspections to pharma companies, as well as helping products pass inspections and plants receive GMP certifications.
Companies implicated in the probe reportedly include Genuine Chemical Pharmaceutical, CBC Biotechnological & Pharmaceutical, Wei Li Pharmaceutical, Paitun Biochemical Pharmacy, Dersan Pharmaceutical and Kuang Nan Pharmaceutical.
Read the Taipei Times article
